Clinical Trials

/ Patients / Clinical Trials

We are currently studying itolizumab in a number of clinical trials in diseases where immuno-inflammation plays a role, including graft-versus-host disease, uncontrolled moderate to severe asthma, and SLE / lupus nephritis.

To learn more about our ongoing clinical trials please visit www.clinicaltrials.gov and search “EQ001” or email clinicaltrials@equilliumbio.com.